Replies to post #817900 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Yes. Due to DCVax-L being a very personalized cell therapy with manufacturing and handling in Sawston UK, location would play a huge role in seeking first approval. Why not the FDA first? well that's the reason.

Yet, NWBO spent a large chunk of money expanding the Cognate capacity to support a US launch.